BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19788472)

  • 1. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
    Hedlund C; Rapoport AM; Dodick DW; Goadsby PJ
    Headache; 2009 Oct; 49(9):1315-23. PubMed ID: 19788472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
    Rapoport AM; Mathew NT; Silberstein SD; Dodick D; Tepper SJ; Sheftell FD; Bigal ME
    Neurology; 2007 Aug; 69(9):821-6. PubMed ID: 17724283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
    Cittadini E; May A; Straube A; Evers S; Bussone G; Goadsby PJ
    Arch Neurol; 2006 Nov; 63(11):1537-42. PubMed ID: 16966497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral zolmitriptan is effective in the acute treatment of cluster headache.
    Bahra A; Gawel MJ; Hardebo JE; Millson D; Breen SA; Goadsby PJ
    Neurology; 2000 May; 54(9):1832-9. PubMed ID: 10802793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study.
    Matharu MS; Levy MJ; Meeran K; Goadsby PJ
    Ann Neurol; 2004 Oct; 56(4):488-94. PubMed ID: 15455406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with intranasal zolmitriptan in cluster headache].
    Pascual J; Navarro A; Caminero AB; Jurado C
    Neurologia; 2006 Apr; 21(3):131-4. PubMed ID: 16575626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is oral zolmitriptan efficacious in the acute treatment of cluster headache?
    Encarnacion JR; Ellis MR; Lindbloom EJ
    J Fam Pract; 2000 Sep; 49(9):784, 849. PubMed ID: 11032200
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.
    Klapper J; Lucas C; Røsjø Ø; Charlesworth B;
    Cephalalgia; 2004 Nov; 24(11):918-24. PubMed ID: 15482352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.